Literature DB >> 20145679

An assessment of the exposure of Americans to perfluorooctane sulfonate: a comparison of estimated intake with values inferred from NHANES data.

Peter P Egeghy1, Matthew Lorber.   

Abstract

To better understand human exposure to perfluorinated compounds (PFCs), a model that assesses exposure to perfluorooctane sulfonate (PFOS) and its precursors from both an intake and a body burden perspective and combines the two with a simple pharmacokinetic (PK) model is demonstrated. Exposure pathways were modeled under "typical" and "contaminated" scenarios, for young children and adults. A range of intakes was also estimated from serum concentrations of PFOS reported in the National Health and Nutrition Examination Survey (NHANES) using a first-order 1-compartment PK model. Total PFOS intakes (medians summed over all pathways) were estimated as: 160 and 2200 ng/day for adults and 50 and 640 ng/day for children under typical and contaminated scenarios, respectively. Food ingestion appears to be the primary route of exposure in the general population. For children, the contribution from dust ingestion is nearly as great as from food ingestion. Pathway-specific contributions span several orders of magnitude and exhibit considerable overlap. PK modeling suggests central tendency PFOS intakes for adults range between 1.6 and 24.2 ng/kg-bw/day, and the forward-based intake estimates are within this range. The favorable comparison reported between the forward-modeled and the back-calculated range of intake predictions lends validity to the proposed framework.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20145679     DOI: 10.1038/jes.2009.73

Source DB:  PubMed          Journal:  J Expo Sci Environ Epidemiol        ISSN: 1559-0631            Impact factor:   5.563


  25 in total

1.  Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood.

Authors:  Samantha L Kingsley; Melissa N Eliot; Karl T Kelsey; Antonia M Calafat; Shelley Ehrlich; Bruce P Lanphear; Aimin Chen; Joseph M Braun
Journal:  Environ Res       Date:  2018-05-07       Impact factor: 6.498

2.  Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011.

Authors:  L-M L Toms; J Thompson; A Rotander; P Hobson; A M Calafat; K Kato; X Ye; S Broomhall; F Harden; J F Mueller
Journal:  Environ Int       Date:  2014-06-27       Impact factor: 9.621

3.  Per- and Polyfluoroalkyl Substances and Obesity, Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: A Review of Epidemiologic Findings.

Authors:  Weipeng Qi; John M Clark; Alicia R Timme-Laragy; Yeonhwa Park
Journal:  Toxicol Environ Chem       Date:  2020-05-22       Impact factor: 1.437

4.  Breastfeeding as an Exposure Pathway for Perfluorinated Alkylates.

Authors:  Ulla B Mogensen; Philippe Grandjean; Flemming Nielsen; Pal Weihe; Esben Budtz-Jørgensen
Journal:  Environ Sci Technol       Date:  2015-08-20       Impact factor: 9.028

5.  Shifting Global Exposures to Poly- and Perfluoroalkyl Substances (PFASs) Evident in Longitudinal Birth Cohorts from a Seafood-Consuming Population.

Authors:  Clifton Dassuncao; Xindi C Hu; Flemming Nielsen; Pál Weihe; Philippe Grandjean; Elsie M Sunderland
Journal:  Environ Sci Technol       Date:  2018-03-12       Impact factor: 9.028

Review 6.  Early-life exposure to EDCs: role in childhood obesity and neurodevelopment.

Authors:  Joseph M Braun
Journal:  Nat Rev Endocrinol       Date:  2016-11-18       Impact factor: 43.330

7.  Application of a combined aggregate exposure pathway and adverse outcome pathway (AEP-AOP) approach to inform a cumulative risk assessment: A case study with phthalates.

Authors:  Rebecca A Clewell; Jeremy A Leonard; Chantel I Nicolas; Jerry L Campbell; Miyoung Yoon; Alina Y Efremenko; Patrick D McMullen; Melvin E Andersen; Harvey J Clewell; Katherine A Phillips; Yu-Mei Tan
Journal:  Toxicol In Vitro       Date:  2020-04-08       Impact factor: 3.500

8.  Polyfluorinated compounds in dust from homes, offices, and vehicles as predictors of concentrations in office workers' serum.

Authors:  Alicia J Fraser; Thomas F Webster; Deborah J Watkins; Mark J Strynar; Kayoko Kato; Antonia M Calafat; Verónica M Vieira; Michael D McClean
Journal:  Environ Int       Date:  2013-09-14       Impact factor: 9.621

9.  Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.

Authors:  Anne P Starling; Stephanie M Engel; David B Richardson; Donna D Baird; Line S Haug; Alison M Stuebe; Kari Klungsøyr; Quaker Harmon; Georg Becher; Cathrine Thomsen; Azemira Sabaredzovic; Merete Eggesbø; Jane A Hoppin; Gregory S Travlos; Ralph E Wilson; Lill I Trogstad; Per Magnus; Matthew P Longnecker
Journal:  Am J Epidemiol       Date:  2014-02-20       Impact factor: 4.897

10.  Per- and Polyfluoroalkyl Substance Exposure, Gestational Weight Gain, and Postpartum Weight Changes in Project Viva.

Authors:  Susanna D Mitro; Sharon K Sagiv; Sheryl L Rifas-Shiman; Antonia M Calafat; Abby F Fleisch; Lindsay M Jaacks; Paige L Williams; Emily Oken; Tamarra M James-Todd
Journal:  Obesity (Silver Spring)       Date:  2020-10       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.